"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 2 | 6 | 8 |
| 1996 | 8 | 3 | 11 |
| 1997 | 5 | 3 | 8 |
| 1998 | 3 | 6 | 9 |
| 1999 | 6 | 3 | 9 |
| 2000 | 3 | 8 | 11 |
| 2001 | 10 | 5 | 15 |
| 2002 | 6 | 10 | 16 |
| 2003 | 11 | 9 | 20 |
| 2004 | 13 | 6 | 19 |
| 2005 | 12 | 8 | 20 |
| 2006 | 5 | 14 | 19 |
| 2007 | 16 | 6 | 22 |
| 2008 | 9 | 5 | 14 |
| 2009 | 11 | 14 | 25 |
| 2010 | 11 | 11 | 22 |
| 2011 | 14 | 13 | 27 |
| 2012 | 14 | 12 | 26 |
| 2013 | 17 | 10 | 27 |
| 2014 | 20 | 9 | 29 |
| 2015 | 27 | 10 | 37 |
| 2016 | 22 | 16 | 38 |
| 2017 | 29 | 15 | 44 |
| 2018 | 29 | 8 | 37 |
| 2019 | 23 | 13 | 36 |
| 2020 | 25 | 24 | 49 |
| 2021 | 21 | 20 | 41 |
| 2022 | 6 | 46 | 52 |
| 2023 | 4 | 26 | 30 |
| 2024 | 10 | 14 | 24 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
-
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study. Emerg Microbes Infect. 2024 Dec; 13(1):2421397.
-
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum. Clin Infect Dis. 2024 Sep 26; 79(3):787-794.
-
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir. J Infect Dis. 2024 Sep 23; 230(3):624-634.
-
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial. JAMA Intern Med. 2024 Sep 01; 184(9):1024-1034.
-
Hepatitis C and its treatment in patients with psoriasis: a propensity-matched case-control study. Arch Dermatol Res. 2024 Aug 29; 316(8):580.
-
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula. Cancer Lett. 2024 Nov 01; 604:217198.
-
Antiviral treatment and prophylaxis for influenza. Lancet. 2024 Aug 24; 404(10454):726-727.
-
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models. Nat Commun. 2024 Jul 18; 15(1):6053.
-
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clin Infect Dis. 2024 Jun 14; 78(6):1490-1503.